Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023
  • About Us
    • About Senores
    • Milestone
    • Leadership
    • Partnership
    • Corporate Film
  • Manufacturing
    • Formulations
    • API
  • Products
    • Formulation – Regulated Market
    • Formulation – Emerging Market
    • API
    • Critical Care – Hospital Line
    • Private Label
  • R&D
  • Investors
    • Offer Documents
    • Financials
    • Policies
    • Reports
    • Shareholding Pattern
    • Committees
    • Investor Contacts
    • Announcements
    • Corporate Governance Reports
    • Investor Meet
    • MOA-AOA
    • Reg. 46 of SEBI (LODR) Regulations
  • Contact

Financials
Financials of the Company
    • Updated Annual Report along with Audited Financial Statements for FY 2024-25
    • Annual Report along with Audited Financial Statements for the Financial Year 2024-2025
    • Senores Pharmaceuticals Ltd Unaudited Standalone and Consolidated Financial Results for Q1 and FY25-26
    • Senores Pharmaceuticals Ltd Audited Consolidated and Standalone Financial Results for Q4 and FY24-25
    • Senores Pharmaceuticals Ltd Un-audited Consolidated and Standalone Financial Results for Q3 and 9MFY25
    • Senores Pharmaceuticals Ltd. Consolidated Financials FY 23-24
    • Senores Pharmaceuticals Ltd. Consolidated Financials FY 22-23
    • Senores Pharmaceuticals Ltd. Consolidated Financials FY 21-22
    • Senores Pharmaceuticals Ltd. Standalone Financials FY 23-24
    • Senores Pharmaceuticals Ltd. Standalone Financials FY 22-23
    • Senores Pharmaceuticals Ltd. Standalone Financials FY 21-22
Financials of Material Subsidiaries
  • Havix Group Inc. – Financials FY 2025
  • Ratnatris Pharmaceuticals Private Limited – Financials FY 2025
  • Senores Pharmaceuticals Inc. – Financials FY 2025
  • Havix Group Inc. – Financials FY 2024
  • Ratnatris Pharmaceuticals Pvt. Ltd. – Financials FY 2024
  • Senores Pharmaceuticals Inc. – Financials FY 2024
  • Senores Pharmaceuticals Inc. – Financials FY 2022 & FY 2023
Group Companies Data
  • Group Companies Data
Related Party Transactions
  • Related Party Transactions FY 2022, FY 2023 & FY 2024

Useful Links

  • About Us
  • Manufacturing
  • Products
  • Partnership
  • R&D
  • Regulatory
  • Adverse Drug Reaction Reporting Form
  • Media
  • Career
  • Contact

Disclaimer

• All the information present on Senores Pharmaceuticals website is not applicable to all the countries across the world. The  purpose  of   this  website is to provide information about Senores Pharmaceuticals' products and services. Any information present on the website shouldn't be misused or construed to spread or promote any of the products in the countries where are disapproved or prohibited.
• Listed  products  in this website will not be supplied to countries in which these could be in conflict with existing valid patents. The buyers should make their independent evaluation of the patent scenario for their respective market as the final responsibility lies exclusively with the buyer.
• Patented products will only be supplied for development, testing, and regulatory submission purposes.

© 2023 Senores Pharmaceuticals | All Rights Reserved.